Nevus Count, Pigmentary Characteristics, and Melanoma-specific Mortality among Norwegian Women with Melanoma >1.0 mm Thick.
Journal
Acta dermato-venereologica
ISSN: 1651-2057
Titre abrégé: Acta Derm Venereol
Pays: Sweden
ID NLM: 0370310
Informations de publication
Date de publication:
04 Apr 2023
04 Apr 2023
Historique:
received:
29
07
2022
accepted:
24
01
2023
medline:
6
4
2023
entrez:
4
4
2023
pubmed:
5
4
2023
Statut:
epublish
Résumé
Little is known about if and how nevi and pigmentation are associated with melanoma-specific mortality. However, increased melanoma awareness in people with lighter pigmentation and many nevi may result in earlier diagnosis of thinner less-lethal tumors. The aim of this study was to investigate associations between nevus count (asymmetrical > 5 mm and small symmetrical), pigmentary characteristics (hair colour, eye colour, skin colour, freckling, pigmentary score), and melanoma-specific mortality in subjects with melanomas > 1 mm. Data from the Norwegian Women and Cancer cohort, established in 1991, with complete follow-up of melanoma patients until 2018 through the Cancer Registry of Norway, were used to estimate hazard ratios with 95% confidence intervals for the associations between nevus count, pigmentary characteristics, and melanoma-specific mortality, stratified by tumor thickness using Cox regression. Estimated hazard ratios consistently indicated a higher risk of melanoma death for those with darker vs lighter pigmentary characteristics in patients with tumors > 1.0-2.0 mm and > 2.0 mm thick (e.g. pigmentary score hazard ratio 1.25, 95% confidence interval (0.74-2.13)). Among women with melanomas > 1.0 mm thick, lighter pigmentation and asymmetrical nevi may be associated with lower melanoma-specific mortality, suggesting that factors that increase the risk of melanoma may also be associated with decreased risk of death from melanoma.
Identifiants
pubmed: 37014267
doi: 10.2340/actadv.v103.4403
pmc: PMC10108620
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
adv4403Références
Br J Dermatol. 2007 May;156(5):938-44
pubmed: 17381454
JAMA. 2016 Jan 5;315(1):68-76
pubmed: 26746459
Eur J Cancer. 2008 Jun;44(9):1275-81
pubmed: 18406602
Melanoma Res. 2020 Apr;30(2):179-184
pubmed: 31574530
Oncogene. 2014 May 8;33(19):2413-22
pubmed: 23728340
G Ital Dermatol Venereol. 2010 Feb;145(1):37-45
pubmed: 20197744
Int J Cancer. 2015 Dec 15;137(12):3006-7
pubmed: 26095813
Int J Epidemiol. 2008 Feb;37(1):36-41
pubmed: 17644530
J Am Acad Dermatol. 2019 May;80(5):1284-1291
pubmed: 30639880
Eur J Cancer. 2013 Aug;49(12):2705-16
pubmed: 23583439
Arch Dermatol. 2006 Dec;142(12):1551-8
pubmed: 17178980
Pigment Cell Melanoma Res. 2012 May;25(3):384-94
pubmed: 22325793
Cancer. 2004 Nov 1;101(9):2067-78
pubmed: 15372475
J Natl Cancer Inst. 2003 Oct 15;95(20):1530-8
pubmed: 14559875
Cancer Treat Res. 2016;167:17-49
pubmed: 26601858
Sci Rep. 2018 Jul 19;8(1):10947
pubmed: 30026606
Dermatology. 2017;233(1):1-15
pubmed: 28463841
J Natl Cancer Inst. 2005 Feb 2;97(3):195-9
pubmed: 15687362
J Am Acad Dermatol. 2018 Jul;79(1):118-125.e1
pubmed: 29580861
Melanoma Res. 2019 Aug;29(4):445-446
pubmed: 31246726
JAMA Dermatol. 2021 Dec 01;157(12):1425-1436
pubmed: 34730781
JAMA Oncol. 2022 May 1;8(5):755-759
pubmed: 35323844
Am J Hum Genet. 2010 Jul 9;87(1):6-16
pubmed: 20602913
Cancer Epidemiol Biomarkers Prev. 1999 Nov;8(11):971-8
pubmed: 10566551
JAMA Dermatol. 2015 Sep;151(9):982-90
pubmed: 26039788
Melanoma Res. 2008 Feb;18(1):1-9
pubmed: 18227701
Br J Dermatol. 2020 Jan;182(1):138-146
pubmed: 31016712
Acta Derm Venereol. 2021 Apr 29;101(4):adv00446
pubmed: 33880571
Cancer Epidemiol Biomarkers Prev. 2019 Jan;28(1):217-224
pubmed: 30341099
J Am Acad Dermatol. 2005 Jan;52(1):40-7
pubmed: 15627079
Int J Cancer. 2018 Dec 15;143(12):3097-3105
pubmed: 29987865
J Transl Med. 2022 Sep 5;20(1):403
pubmed: 36064556
FASEB J. 2010 Oct;24(10):3850-60
pubmed: 20519635
CA Cancer J Clin. 2017 Mar;67(2):93-99
pubmed: 28094848
Pigment Cell Melanoma Res. 2019 Jul;32(4):593-600
pubmed: 30706692
Int J Cancer. 2016 Sep 15;139(6):1217-22
pubmed: 27101944
Epidemiology. 2017 May;28(3):379-386
pubmed: 28244888
Melanoma Res. 2016 Aug;26(4):401-8
pubmed: 26990272
Int J Cancer. 2015 Oct 1;137(7):1691-8
pubmed: 25809795